Clinical Trial: Early Intervention in High Risk CCUS

U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802146) titled 'Early Intervention in High Risk CCUS' on Jan. 27.

Brief Summary: This research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unknown Significance (CCUS). This study will give eligible CCUS participants the option of either being observed or taking an oral drug as treatment.

The names of the study drug involved in this study is:

-Decitabine/cedazuridine (DEC/CED) (a nucleoside metabolic inhibitor and cytidine deaminase inhibitor).

Study Start Date: Jan., 2025

Study Type: INTERVENTIONAL

Condition: Clonal Cytopenia of Undetermined Signifi...